All In MedTech

FDA Clearance Tracker · P000039-S019

AMPLATZER SEPTAL OCCLUDER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 16, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P000039-S019
Device name
AMPLATZER SEPTAL OCCLUDER
Applicant location
St. Paul, MN
Received
Sep 1, 2006
Decided
Aug 16, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P000039

Device type

Device class
Class III

Every decision under product code MAE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE POST APPROVAL STUDY.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.